Now I have sufficient information to write the consolidated review. Let me produce the final assessment.

## Summary
This paper presents OpenMeta, a benchmark for metagenomic functional prediction that integrates 14 datasets and evaluates 23 models across three dimensions (pre-trained vs. not, general vs. specialized, sequence vs. hierarchical). The motivation is legitimate — the field lacks standardized benchmarks — and the curation and evaluation effort is substantial. The paper also identifies an interesting gap (no unified model for sequence and hierarchical data).

## Strengths
- **First systematic benchmark comparing genomic and metagenomic pre-trained models.** Tables 2 and A1 explicitly contrast the downstream tasks of genomic pre-trained models (DNABERT2, HyenaDNA, NT) with those of the metagenomic model FGBERT, showing that genomic benchmarks rely on single-species, binary tasks while OpenMeta integrates multi-species, multi-class functional prediction tasks across 14 datasets (Section 4.2, Tables 4–5). This concretely demonstrates a gap that prior work did not surface.

- **Large-scale comparative evaluation across 23 models and three dimensions genuinely differentiates model capabilities.** Table 3 categorizes all methods; results (Tables 6–9, A5–A6) consistently show that FGBERT (the only metagenomic pre-trained model) outperforms genomic pre-trained models (DNABERT2, HyenaDNA, NT) and traditional methods. This provides direct evidence that the benchmark can surface meaningful differences — genomic models do systematically struggle on these metagenomic tasks.

- **Identification of a research gap: no unified model for sequence and hierarchical data.** Section 5.2(B) and the Conclusion (lines 361–363) explicitly note this gap; Table 12 shows the specialized hierarchical model PopPhy-CNN outperforming general models on the Cirrhosis dataset, while no model processes both sequence and tree-structured data. This observation is concrete and actionable for future work.

- **Task-specific metrics tailored to domain needs.** Section 4.3 incorporates False Negative Rate (FNR) for fine-grained ARG prediction (Table 10), justified by the real-world severity of missing resistance genes. This goes beyond generic accuracy reporting.

## Weaknesses

### Fatal
None.

### Major
- **Data decontamination between FGBERT's pre-training data and evaluation datasets is not addressed.** FGBERT is pre-trained on MGnify (~2.97B metagenomic sequences). The paper provides no analysis of whether sequences from evaluation datasets (VFDB, NCycDB, CARD, etc.) — or close variants — appear in MGnify. For a benchmark paper whose central result is that the metagenomic pre-trained model dramatically outperforms all competitors, this is a non-negotiable omission. Without a decontamination analysis, the reported advantage could partially reflect data overlap rather than genuine generalization. The paper should report removal of evaluation-set sequences from the pre-training corpus at some identity threshold (e.g., 95% nucleotide identity) or show the overlap is negligible.

- **Only one metagenomic pre-trained model (FGBERT) is included, yet the paper makes broad claims about "the superior performance of metagenomic pre-trained models."** Lines 43–53, the abstract, and the conclusion advocate for metagenomic pre-trained models as a class. However, among the 23 models evaluated, FGBERT is the sole metagenomic pre-trained model. ViBE (pre-trained with MLM on viral metagenomic data, line 92, 168, 182) is included only as a "specialized" model used with its off-the-shelf K-mer embeddings rather than fine-tuned as a pre-trained competitor. LookingGlass (line 90–91) is mentioned in related work but not evaluated. The paper should either: (a) fine-tune ViBE as a comparable metagenomic pre-trained model and include results, or (b) explicitly acknowledge that the field currently lacks alternative metagenomic pre-trained models and temper the "metagenomic pre-trained models" claim to refer specifically to FGBERT. As written, the claim conflates a single model's performance with a whole model class.

- **The benchmarks are drawn from FGBERT's original evaluation suite without sufficient acknowledgment of what this entails.** The paper states it is "based on the FGBERT model" (line 47) and "incorporating FGBERT's multi-species metagenomic datasets" (line 153/671). While the datasets themselves are standard public databases (RegulonDB, CARD, PATRIC, ENZYME, VFDB, NCycDB, NCRD), the task formulations and evaluation splits follow FGBERT's original design. This is not inherently problematic — reusing well-established tasks is standard practice — but the paper should clarify: (1) which design choices (e.g., data splits, class groupings) are inherited from FGBERT vs. independently designed, and (2) to what extent the benchmark provides new community value beyond FGBERT's original evaluation. The current framing risks the perception that this is FGBERT's evaluation repackaged rather than an independent community resource.

### Minor
- **Claims of "comprehensive" coverage are overstated.** The paper focuses on *multi-class functional gene prediction* from sequences and hierarchical abundance data (gene operons, ARGs, pathogenicity, enzymes, virulence factors, N-cycling, disease phenotype). This is already substantial. However, metagenomic analysis also includes taxonomic profiling, binning, viral discovery, and assembly evaluation — none of which are covered. The abstract and introduction (lines 39–40, 47–48) claim to be "the first comprehensive benchmark for metagenomic research" and "sets a new standard." Narrowing the scope to functional prediction would better match what is delivered.

- **Hyperparameter tuning for general models (SVM, RF, CNN, LSTM, Transformer) is insufficiently documented.** The implementation details (line 699–700) state "consistent settings across all datasets" following default hyperparameters from the respective publications. General models like SVM and RF typically require per-dataset tuning (e.g., kernel choice, C, tree depth) to produce competitive baselines. The paper should report whether any task-specific tuning was performed and, if not, acknowledge that these baselines may underperform relative to their potential.

- **Fine-grained NCRD benchmark omits genomic pre-trained models.** Only FGBERT, DeepARG, RGI, and PLM-ARG are evaluated on the fine-grained NCRD dataset (line 264–276). DNABERT2, HyenaDNA, and NT — which were evaluated on other tasks — are absent here. While some of these models may not be suitable for fine-grained ARG classification in their current form, the omission should be justified and ideally addressed.

- **Statistical significance is not discussed.** The checklist (line 690–692) claims error bars are reported, but the text does not discuss whether observed performance gaps (e.g., FGBERT vs. DNABERT2 on any dataset) are statistically significant. Given small class sizes in some datasets (e.g., ENZYME has 7 classes), reported macro F1 differences could be sensitive to random seeds or train/test splits. The paper should explicitly state the number of runs and report variance.

- **Hierarchical data benchmark is thin.** Only two datasets (Cirrhosis, n=232; T2D, n=440) are included, and the comparison is limited to PopPhy-CNN vs. four general classifiers. The paper asserts (line 285–286) that LSTM and Transformer are not tested "because they are mainly applicable to sequence data" — but hierarchical data could be flattened or adapted for these models. This is a missed opportunity to explore whether sequence-aware models offer benefits on tree-structured data.

### Trivial
- The phrase "based on the FGBERT model" (line 47) is ambiguous — it is unclear whether this means the codebase, task design, or selection of datasets. Clarify.
- Figure/table references in the text (e.g., "A5 and A6 show M.F1" line 280) appear incomplete due to parsing artifacts.

## Nice-to-Haves
- Including LookingGlass (a 3-layer LSTM pre-trained on bacterial/archaeal data, mentioned in related work) as an additional metagenomic pre-trained baseline would strengthen comparisons.
- Adding synthetic or simulated hierarchical data with known ground-truth phylogenetic structure could better demonstrate the utility of tree-based methods.

## Removed Points
These points are flagged to be removed; treat them with caution.
- **Criticism that the paper claims existing models "often perform poorly on metagenomic tasks" (line 42) is "supported only by the paper's own experiments, which may be biased."** This is speculative — the paper's experiments are the evidence for this claim, and reviewers should evaluate whether those experiments are sound, not speculate about hypothetical bias.
- **Criticism that the Background section (Sec. 3.1) is "largely textbook material" and "sequencing costs" comment is irrelevant.** Textbook-level background in a cross-disciplinary paper is standard; one sentence on cost is not a weakness.
- **Criticism that results "rely heavily on the reader inspecting garbled table images."** This is a parser artifact; the original submission's tables are not garbled.
- **Criticism that Observations and Insights "largely restate Table 14."** The section provides contextual comparison across five dimensions (pre-training data, tokenization, architecture, tasks, benchmarks); this is meaningful synthesis, not restatement.
- **Criticism about "partly contrived" (line 42) being unsubstantiated.** The paper is characterizing prior datasets, not making a technical claim — this is rhetorical framing, not evidence.
- **Strength Finder claims that the paper is "the first metagenomic benchmark that systematically demonstrates the inadequacy of existing genomic benchmarks" — concerns about overclaiming are addressed in weaknesses above, but the core benchmarking effort remains a genuine strength.**

## Novel Insights
The most interesting observation to emerge across the reviews is that the paper's contribution sits in an awkward middle ground: it is too broad to be a neutral community benchmark (only one metagenomic pre-trained model, datasets inherited from FGBERT's design) yet too narrow to be a comprehensive metagenomic analysis (limited to functional gene prediction, missing taxonomic profiling, viral discovery, etc.). The most impactful framing would be a middle position: "a curated, standardized evaluation suite for metagenomic *functional gene prediction* that surfaces the gap between genomic and metagenomic pre-training." The paper itself identifies the most genuinely novel finding — the lack of unified models for sequence + hierarchical data — but this insight emerges from a small corner of the benchmark (two disease datasets) rather than being the paper's main thrust.

## Suggestions
1. **Add decontamination analysis.** Report the fraction of sequences in each evaluation dataset that match MGnify sequences at ≥95% nucleotide identity. If overlap is negligible, state this explicitly.
2. **Include ViBE as a fine-tuned metagenomic pre-trained baseline** (not just as a frozen feature extractor). If the authors lack compute, at minimum acknowledge this limitation and drop "metagenomic pre-trained models" (plural) claims.
3. **Clarify the relationship to FGBERT.** State explicitly what "based on the FGBERT model" means (code infrastructure? task design? datasets?) and which design choices are inherited vs. independently made.
4. **Narrow the scope claim** from "comprehensive benchmark for metagenomic research" to "comprehensive benchmark for metagenomic functional gene prediction."
5. **Add statistical significance analysis** (multiple runs with standard deviations or a significance test) for key comparisons, especially where the gap is small.

## Score and Decision

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Accept</decision>